World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Slovenia
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
17012
World Ranking
5139
National Ranking
3

Janko Kos publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Janko Kos sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 319 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Janko Kos D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Janko Kos sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2025 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2023 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2022 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Janko Kos is affiliated with the University of Ljubljana in Slovenia and has a significant research output in fields primarily related to medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their main research areas include molecular biology, immunology, oncology, cancer research, and physiology.

The scientist's work covers several key research topics such as protease and inhibitor mechanisms, peptidase inhibition and analysis, immune cell function and interaction, immune cells in cancer, neuroscience and neuropharmacology research, cell adhesion molecules research, and cholinesterase and neurodegenerative diseases.

Frequent co-authors collaborating with Janko Kos include Anja Pišlar, Ana Mitrović, Stanislav Gobec, Emanuela Senjor, and Milica Perišić Nanut.

Janko Kos has published numerous papers, some of the recent notable ones are:

  • The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors, 2020, PLoS Pathogens
  • Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery, 2022, Biomedicine & Pharmacotherapy
  • N-alkylpiperidine carbamates as potential anti-Alzheimer's agents, 2020, European Journal of Medicinal Chemistry
  • Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and B, 2020, Journal of Medicinal Chemistry
  • Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity, 2020, European Journal of Medicinal Chemistry

The frequent publication venues for their research include:

  • International Journal of Molecular Sciences
  • Frontiers in Immunology
  • European Journal of Medicinal Chemistry
  • The Cambridge Structural Database
  • Cellular and Molecular Life Sciences

Janko Kos has also contributed to academic literature through book publications. Publishers include Založba Univerze v Ljubljani (University of Ljubljana Press) eBooks and Znanstvena založba Filozofske fakultete Univerze v Ljubljani (Ljubljana University Press, Faculty of Arts) eBooks.

  • Spomin jezika, jezik spomina: študije o pesniškem jeziku, 2022
  • Janko Kos in slovenska primerjalna književnost, 2023
  • Trojka s filozofske: spisi o Vebru, Bartolu in Jugu, 2020

The scientist has been recognized as a member of the European Academy of Sciences and Arts.

Best Publications

  • The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.

    W. Bode;R. Engh;D. Musil;U. Thiele

  • Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.

    Petra Kocbek;Nataša Obermajer;Mateja Cegnar;Janko Kos

  • Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).

    J Kos;T T Lah

  • Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

    Boris Brus;Urban Košak;Samo Turk;Anja Pišlar

  • Cysteine Proteinase Inhibitors Stefin A, Stefin B, and Cystatin C in Sera from Patients with Colorectal Cancer: Relation to Prognosis

    Janko Kos;Marta Krašovec;Nina Cimerman;Hans Jørgen Nielsen

  • Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer.

    Vito Turk;Boris Turk;Gregor Gunčar;Dušan Turk

  • Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.

    J Kos;B Stabuc;A Schweiger;M Krasovec

  • Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients.

    Nina Cimerman;Pika Meško Brguljan;Marta Krašovec;Stanislav Šuškovič

  • Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer.

    J Kos;B Werle;T Lah;N Brunner

  • Cystatins in Immune System

    Špela Magister;Janko Kos

  • Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor.

    Werner Machleidt;Werner Machleidt;Ulrich Thiele;Ulrich Thiele;Bernd Laber;Bernd Laber;Irmgard Assfalg-Machleidt;Irmgard Assfalg-Machleidt

  • Serum Cystatin C, a New Marker of Glomerular Filtration Rate, Is Increased during Malignant Progression

    Janko Kos;Borut S̆tabuc;Nina Cimerman;Nils Brünner

  • Proteins of higher fungi – from forest to application

    Jana Erjavec;Janko Kos;Maja Ravnikar;Tanja Dreo

  • Cysteine cathepsins (proteases)—On the main stage of cancer?

    Vito Turk;Janko Kos;Boris Turk

  • Microbial and fungal protease inhibitors—current and potential applications

    Jerica Sabotič;Janko Kos

  • Prognostic significance of cathepsins B and L in primary human breast cancer.

    J. A. Foekens;J. Kos;H. A. Peters;M. Krasovec

  • Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.

    Aleš Premzl;Valentina Zavašnik-Bergant;Vito Turk;Janko Kos

  • Cysteine proteinases in cancer progression and their clinical relevance for prognosis.

    T T Lah;J Kos

  • Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins.

    Boris Turk;Joseph G. Bieth;Ingemar Björk;Iztok Dolenc

  • Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.

    Strojnik T;Kos J;Zidanik B;Golouh R

Frequent Co-Authors

Stanislav Gobec
Stanislav Gobec University of Ljubljana
Vito Turk
Vito Turk Jožef Stefan Institute
Tamara T. Lah
Tamara T. Lah National Institute of Biology
Dušan Turk
Dušan Turk Jožef Stefan Institute
Anahid Jewett
Anahid Jewett University of California, Los Angeles
Boris Turk
Boris Turk Jožef Stefan Institute
Borut Štrukelj
Borut Štrukelj University of Ljubljana
Florian Nachon
Florian Nachon Centre national de la recherche scientifique, CNRS
Nils Brünner
Nils Brünner University of Copenhagen
Wolfram Bode
Wolfram Bode Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Janko Kos

Trending Scientists